Literature DB >> 29111017

Dopamine agonist withdrawal syndrome in Parkinson's disease.

Paolo Solla1, Alfonso Fasano2, Antonino Cannas3, Francesco Marrosu3.   

Abstract

Entities:  

Keywords:  DAWS; Parkinson's disease

Mesh：

Substances：

Year:  2017        PMID： 29111017     DOI： 10.1016/j.jns.2017.08.3263

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  2 in total

Review 1.  Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review.

Authors:  Amnon A Berger; Ariel Winnick; Alexandra Welschmeyer; Alicia Kaneb; Kevin Berardino; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Neurol Int       Date:  2020-12-08

2.  Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease.

Authors:  Marco Onofrj; Angelo Di Iorio; Claudia Carrarini; Mirella Russo; Raffaella Franciotti; Alberto J Espay; Laura S Boylan; John-Paul Taylor; Massimo Di Giannantonio; Giovanni Martinotti; Enza M Valente; Astrid Thomas; Laura Bonanni; Stefano Delli Pizzi; Fedele Dono; StefanoL Sensi
Journal:  Mov Disord       Date:  2021-08-24       Impact factor: 9.698
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.